Monday 14 May
Research supports long-term efficacy and safety of Lucentis and benefits of individualised treatment
In the next issue of HPE, Hospital Oncology & Haematology Europe supplement fills the unmet need for a publishing voice for what has become a Europe-wide initiative.
|
Latest News Other newsFriday 11 May
Thursday 10 May
Thursday 10 May
Wednesday 9 May
Monday 30 April
Industry News
Monday 14 May
Research supports long-term efficacy and safety of Lucentis and benefits of individualised treatment
Monday 14 May
Marie-Laure Pochon will resign as Executive Vice President Commercial Operations for private reasons
Wednesday 9 May
Lundbeck Executive Vice President says the results back Lu AA21004 as a multimodal antidepressant
|
Roundtable
Iron sucrose complex drugs - identical or just similar?
Continuing the series of HPE Pharmacist Roundtable Meetings on complex non-biological drugs, a panel of senior European hospital pharmacists and renal specialists met in Utrecht, The Netherlands, to discuss insights and advances in the field and to consider the evidence for therapeutic differences between iron sucrose originator and iron sucrose similar preparations.
Regulation of complex molecules
Roundtable meetings in London and Paris discussed evidence for therapeutic differences between the originator iron sucrose and iron sucrose similars and called for a new regulatory pathway for non-biological complex molecules.
Supplements HPE supplements are created to provide readers with dedicated resources and materials for specific areas of hospital pharmacy. Click on the images below to access the latest supplements: Hospital Oncology & Haematology Europe, Cytotoxics and Multiple Sclerosis |